|
DYNC1LI2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62914126633495E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.35231842285566E-12 |
| Normal-vs-Stage2 |
1.25920000004776E-06 |
| Normal-vs-Stage3 |
1.4299672557172E-13 |
| Normal-vs-Stage4 |
6.63089583241572E-11 |
| Stage1-vs-Stage2 |
6.787800E-01 |
| Stage1-vs-Stage3 |
2.912000E-02 |
| Stage1-vs-Stage4 |
7.342300E-02 |
| Stage2-vs-Stage3 |
6.467800E-02 |
| Stage2-vs-Stage4 |
7.870000E-02 |
| Stage3-vs-Stage4 |
9.089400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.76996261670138E-15 |
| Normal-vs-AfricanAmerican |
4.567500E-04 |
| Normal-vs-Asian |
4.81190000067855E-08 |
| Caucasian-vs-AfricanAmerican |
2.238200E-01 |
| Caucasian-vs-Asian |
5.536800E-01 |
| AfricanAmerican-vs-Asian |
4.755600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.91730006607827E-11 |
| Normal-vs-Female |
1.63880020664919E-12 |
| Male-vs-Female |
6.613000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.64259758309527E-11 |
| Normal-vs-Age(41-60Yrs) |
1.17079679284871E-11 |
| Normal-vs-Age(61-80Yrs) |
2.30593322214645E-12 |
| Normal-vs-Age(81-100Yrs) |
1.971500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.923700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.624200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.344800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.401000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.333600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.817400E-04 |
| Classical-VS-Follicular |
5.275800E-01 |
| Classical-VS-Other |
8.196200E-01 |
| Classical-VS-Normal |
4.17110790351671E-12 |
| Tall-VS-Follicular |
1.371880E-02 |
| Tall-VS-Other |
1.379170E-01 |
| Tall-VS-Normal |
3.0053737276603E-12 |
| Follicular-VS-Other |
9.926200E-01 |
| Follicular-VS-Normal |
1.84699999739024E-08 |
| Other-VS-Normal |
8.384000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.41755529326338E-12 |
| Normal-vs-N1 |
3.41599970532513E-10 |
| N0-vs-N1 |
3.790000E-01 |
|
|
